Expedient multi-step synthesis of organometallic complexes of Tc and Re in high effective specific activity. A new platform for the production of molecular imaging and therapy agents.
For over thirty years, instant labeling kits which involve no purification steps have been the only method used to prepare (99m)Tc radiopharmaceuticals for clinical studies. To address the limitations imposed by instant kits, which is hindering the development of molecularly targeted Tc- and Re-based imaging and therapy agents, a new strategy for the rapid multistep synthesis and purification of organometallic technetium-based molecular probes and corresponding rhenium-based therapeutic analogues was developed. Beginning with MO4(-) (M = (99m)Tc, (186/188)Re), the carbonyl precursor [M(CO)3(H2O)3](+) was synthesized in 3 min in quantitative yield in a microwave reactor. A dipicolyl ligand was added and the chelate complex was formed in high yield in 2 min using microwave heating at 150 degrees C. This was followed by a new purification strategy to remove unlabeled ligand which entailed using a copper resin/C18 solid phase extraction protocol giving the desired product in greater than 78% decay corrected yield (dcy). Conversion to the corresponding succinimidyl active ester was achieved following a 5 min microwave irradiation at 120 degrees C and C18 solid phase extraction purification in 60% dcy. A series of amides were prepared subsequently by microwave heating at 120 degrees C for 5 min producing the desired targets in greater than 86% dcy. The reported method represents a move away from traditional instant kits toward more versatile platform synthesis and purification technologies that are better suited for producing modern molecular imaging and therapy agents.
Causey
Patrick W
PW
McMaster Nuclear Reactor, McMaster University, Hamilton, Canada, L8S 4M1.
Besanger
Travis R
TR
Schaffer
Paul
P
Valliant
John F
JF
D002614:Chelating Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D003432:Cross-Linking Reagents / Q000138:chemical synthesis / Q000627:therapeutic use; D005374:Filtration; D008872:Microwaves; D009942:Organometallic Compounds / Q000138:chemical synthesis* / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D012211:Rhenium / Q000737:chemistry*; D012680:Sensitivity and Specificity; D013667:Technetium / Q000737:chemistry*
D002614:Chelating Agents; D003432:Cross-Linking Reagents; D009942:Organometallic Compounds; D012211:Rhenium; D013667:Technetium